⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Promethean Drug Ideas and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Promethean Drug Ideas
↗Thane, India
Promethean Drug Ideas is a specialized scientific consulting firm founded in 2020 that supports pharmaceutical, biotech, and venture capital companies. The firm provides high-level scientific assessments, competitive intelligence, and end-to-end research roadmaps, ranging from early discovery ideation to IND-enabling studies.
The company focuses on bridging the gap between breakthrough science and global business opportunities. Their expertise spans various therapeutic modalities, including small molecules, biologics, cell and gene therapies, and oligonucleotides, with a particular emphasis on chronic diseases and precision medicine.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Scientific Consulting / Drug Discovery R&D
SIZE & FINANCIALS
Employees:1-50
Founded:2020
Ownership:private
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Consultancy/Advisory (No proprietary pipeline)
Modalities:Small molecule, mAb, Peptides, Cell therapy, Gene therapy, Oligonucleotide therapeutics, Microbiome
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Pharmaceutical MNCs, Biotech startups, Academic institutions, Venture Capital firms
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Dr. Neelima Khairatkar Joshi - Founder & President
Scientific Founders:Dr. Neelima Khairatkar Joshi
LINKS
Website:prometheandrugideas.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Promethean Drug Ideas. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.